FCGR3A and B-cell chronic lymphocytic leukemia: Similarly, another group demonstrated the in vitro anti-CLL cytotoxicity of a CAR-NK expressing CD19 CAR, high-affinity non-cleavable CD16, and a membrane-bound IL-15/IL-15R fusion molecule [265].